In a study published last week in The New England Journal of Medicine, British drugmaker AstraZeneca said that in a late-stage trial, its drug Lynparza reduced the risk of relapse and death in breast cancer patients with certain gene mutations.
Lynparza was developed with Merck, and works to inhibit PARP, a protein that repairs DNA damage to cells — including those that are cancerous. It can be given as a maintenance therapy or an active treatment after chemotherapy. The study found that compared to a placebo, Lynparza reduced the combined risk of recurrence of breast cancer or death from any cause by 42 percent, Reuters reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Lithium shows promise in Alzheimer's studySpeed Read Potential new treatments could use small amounts of the common metal
-
Scientists discover cause of massive sea star die-offSpeed Read A bacteria related to cholera has been found responsible for the deaths of more than 5 billion sea stars
-
'Thriving' ecosystem found 30,000 feet underseaSpeed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 yearsSpeed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
A potentially mutating bat virus has some scientists worried about the next pandemicUnder the Radar One subgroup of bat merbecovirus has scientists concerned
-
Dehorning rhinos sharply cuts poaching, study findsSpeed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
-
Breakthrough gene-editing treatment saves babyspeed read KJ Muldoon was healed from a rare genetic condition
-
Sea lion proves animals can keep a beatspeed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
